Bioartificial Liver: Its Pros and Cons

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Therapeutic apheresis and dialysis

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1744-9987.2006.00359.xPMID 16684219
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Application of Bioartificial Liver Support Systems

  2004cited by this paper
• Prospective, Randomized, Multicenter, Controlled Trial of a Bioartificial Liver in Treating Acute Liver Failure

  2004cited by this paper
• Pathogenesis of Hepatic Encephalopathy in Acute Liver Failure

  2003cited by this paper
• Prometheus--a new extracorporeal system for the treatment of liver failure.

  2003cited by this paper
• Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells.

  2003cited by this paper
• The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers.

  2002cited by this paper
• High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure.

  2002cited by this paper
• A case of acute hepatic insufficiency treated with novel plasmapheresis plasma diafiltration for bridge use until liver transplantation.

  2002cited by this paper
• ASSESSMENT OF THE AMC-BIOARTIFICIAL LIVER IN THE ANHEPATIC PIG1

  2002cited by this paper
• Biologic Liver Support: Optimal Cell Source and Mass

  2002cited by this paper
• Is continuous veno-venous hemofiltration for acetaminophen-induced acute liver and renal failure worthwhile?

  2002cited by this paper
• Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus.

  2002cited by this paper
• Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy.

  2002cited by this paper
• Recent Developments on Human Cell Lines for the Bioartificial Liver

  2002cited by this paper
• Advances in bioartificial liver devices

  2001cited by this paper
• Experimental Evaluation of a Cell Module for Hybrid Liver Support

  2001cited by this paper
• Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure

  2001cited by this paper
• Severe hepatitis treated with an artificial liver support system

  2001cited by this paper
• Continuous haemofiltration in the intensive care unit

  2000cited by this paper
• Cross‐species transmission of PERV appears unlikely

  2000cited by this paper
• Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial

  2000cited by this paper
• [Clinical trials using cell xenografts. Their place in the treatment of fulminant hepatitis].

  2000cited by this paper
• Metastatic liver tumors.

  2000cited by this paper
• Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system.

  1999cited by this paper
• Surgical treatment of malignant liver tumours.

  1999cited by this paper
• Significantly Improved Survival Time in Pigs with Complete Liver Ischemia Treated with a Novel Bioartificial Liver

  1999cited by this paper
• Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group.

  1999cited by this paper
• Long-term treatment of patients with acute exacerbation of chronic liver failure by albumin dialysis.

  1999cited by this paper
• No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts.

  1998cited by this paper
• Immunological Consequences of the use of Xenogeneic Hepatocytes in a Bioartificial Liver for Acute Liver Failure

  1997cited by this paper
• Cryopreservation of porcine hepatocyte cultures.

  1996cited by this paper
• Pilot‐controlled trial of the extracorporeal liver assist device in acute liver failure

  1996cited by this paper
• Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites.

  1994cited by this paper
• A treatment system for implementing an extracorporeal liver assist device.

  1994cited by this paper
• A Bioartificial Liver to Treat Severe Acute Liver Failure

  1994cited by this paper
• High Volume Plasma Exchange in Fulminant Hepatic Failure

  1992cited by this paper
• Continuous removal of middle molecules by hemofiltration in patients with acute liver failure

  1990cited by this paper
• Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

  1988cited by this paper
• Fulminant and Subfulminant Liver Failure: Definitions and Causes

  1986cited by this paper
• A prospective clinical and immunologic analysis of patients with serum sickness.

  1984cited by this paper
• Dialysis procedures in acute liver coma.

  1976cited by this paper
• Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD).

  1976cited by this paper
• Peritoneal dialysis in liver coma.

  1959cited by this paper
• Ammonia intoxication treated by hemodialysis.

  1958cited by this paper

• Advances, challenges and future applications of liver organoids in experimental regenerative medicine

  2025cites this paper
• Numerical Simulation of Mass Transfer in Hollow Fiber Membrane Module for Membrane-Based Artificial Organs

  2024cites this paper
• Reversal of liver failure using a bioartificial liver device implanted with clinical-grade human-induced hepatocytes.

  2023cites this paper
• Curing Classical Homocysteinuria with Pediatric in vitro engineered Liver Organoid Transplantation?

  2023cites this paper
• Organoid transplant approaches for the liver

  2021cites this paper
• Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening

  2021cites this paper
• HepaRG Self-Assembled Spheroids in Alginate Beads Meet the Clinical Needs for Bioartificial Liver

  2020cites this paper
• Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells.

  2020cites this paper
• Current Status and New Challenges of the Artificial Liver

  2018cites this paper
• A. Cholestatic diseases: 1. Biliary atresia 2. Familial cholestatic syndromes 3. Primary biliary cirrhosis 4. Primary sclerosing cholangitis with development of secondary biliary cirrhosis B. Hepatocellular diseases: 1. Alcoholic cirrhosis 2. Chronic active hepatitis with cirrhosis (hepatitis B or C

  2017cites this paper
• Tissue engineering of the liver

  2016cites this paper
• Biocompatibility evaluation of tissue-engineered decellularized scaffolds for biomedical application.

  2016cites this paper
• A New Fluidized Bed Bioreactor Based on Diversion-Type Microcapsule Suspension for Bioartificial Liver Systems

  2016cites this paper
• Development of a bioreactor based on magnetically stabilized fluidized bed for bioartificial liver

  2015cites this paper
• MicroRNAs in liver tissue engineering - New promises for failing organs.

  2015cites this paper
• Development and validation of a bioartificial liver device with fluidized bed bioreactors hosting alginate-encapsulated hepatocyte spheroids

  2015cites this paper
• Endotoxinämie im Akuten Leberversagen am Grosstiermodell

  2015cites this paper
• Problems and prospects of creation of extracorporal systems for support of the functional state of the liver

  2015cites this paper
• [Problems and prospects of creation of extracorporal systems for support of functional livers status].

  2015cites this paper
• Effect of plasma components on the stability and permeability of microcapsule.

  2014cites this paper
• Histological changes during extracorporeal perfusions of the porcine liver: implications for temporary support during acute liver failures

  2013cites this paper
• Immunosafety Evaluation of a Multilayer Flat-Plate Bioartificial Liver

  2012cites this paper
• ƒJKL%J. # ƒ€ƒ‡ —"‡'ƒ€†Œ‡‰ †‡'‡‰…ˆ ‹ —"‹›Œ‡‚€' '…€"‰‹ƒ…Š… —‡µ‡‰‹µ‰‹" ‰‡'‹ƒ€ƒ‹µ‰‹ƒ…: …ƒ‹"…µ‡Š…" €—‡Šƒ †‹—"‹€, š™‡ƒ†š˜™…‡ †‹‚‹‰‹ƒ… … ‚‰‡‰…ˆ †‡'š™…' —‡ …€Œ…ƒ‹† ‹› ƒ‹" —€ƒ‹Œ‹"…… † ‹†"‡‚‡‰‰‹" '…"š""…µ‡Š‹" —"€Šƒ…Š‡. 6MLNJ+OJ PM#+&: —‡µ‡‰‹µ‰€ˆ ‰‡'‹ƒ€ƒ‹µ‰‹ƒ, ‚‡'€‰…µ‡Š€ˆ ‡Œƒš'€ '…€"‰‹ƒ…Š€.

  2012cites this paper
• Liver Regenerative Medicine: Advances and Challenges

  2012cites this paper
• Advances in cell sources of hepatocytes for bioartificial liver.

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Human liver cell lines for the AMC-bioartificial liver

  2012cites this paper
• Perfusion flow rate substantially contributes to the performance of the HepaRG‐AMC‐bioartificial liver

  2012cites this paper
• The influence of membrane molecular weight cutoff on a novel bioartificial liver.

  2012cites this paper
• Novel therapeutic strategies for prevention of postresectional liver failure

  2012cites this paper
• Extracorporeal Artificial Liver Support Systems

  2011cites this paper
• Use of hepatocyte and stem cells for treatment of post‐resectional liver failure: are we there yet?

  2011cites this paper
• Effects of plasma from acute-on-chronic liver failure patients on immortalized human hepatocytes in vitro.

  2011cites this paper
• Liver Cell Culture Devices.

  2010cites this paper
• Three-Dimensional Culture of Human Embryonic Stem Cell Derived Hepatic Endoderm and Its Role in Bioartificial Liver Construction

  2010cites this paper
• A Combining Method to Enhance the In Vitro Differentiation of Hepatic Precursor Cells

  2010cites this paper
• Isolation and culture of adult human liver progenitor cells: in vitro differentiation to hepatocyte-like cells.

  2010cites this paper
• Standardized intensive care unit management in an anhepatic pig model: new standards for analyzing liver support systems

  2010cites this paper
• Three-dimensional perfusion cultures of mouse and pig fetal liver cells in a packed-bed reactor: effect of medium flow rate on cell numbers and hepatic functions.

  2010cites this paper
• A CRITICAL EVALUATION OF THE MARS TREATMENT IN FINLAND

  2010cites this paper
• Bio-artificial liver support system : an evaluation of models used in demonstrating or improving metabolic and clinical efficacy

  2010cites this paper
• Pathophysiology of Hepatic Encephalopathy: Studies in Animal Models

  2009cites this paper
• Progress in bioreactors of bioartificial livers.

  2009cites this paper
• Hemoglobin‐based oxygen carrier and convection enhanced oxygen transport in a hollow fiber bioreactor

  2009cites this paper
• Novel Polymer Blends for the Preparation of Membranes for Biohybrid Liver Systems

  2009cites this paper
• Hepatic assist devices: Will they ever be successful?

  2009cites this paper
• Isolation of two cytochrome P450 forms, CYP2A19 and CYP1A, from pig liver microsomes.

  2009cites this paper
• Role of dexamethasone and oncostatin M on the formation of vacuoles in human fetal liver cells.

  2009cites this paper
• Macroporous polymeric scaffolds for tissue engineering applications

  2009cites this paper
• Perfluorocarbon facilitated O2 transport in a hepatic hollow fiber bioreactor

  2009cites this paper
• Métodos de soporte de la función hepática

  2008cites this paper
• Progress towards clinical xenotransplantation.

  2008cites this paper
• The Mini Bioartificialiver: a Cellular Biosensor in the Drug Development Process

  2008cites this paper
• Von der Gewebezüchtung zur individuellen Geweberegeneration – Der Mensch als Bioreaktor

  2008cites this paper
• Cells for bioartificial liver devices: The human hepatoma‐derived cell line C3A produces urea but does not detoxify ammonia

  2008cites this paper
• Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells

  2008cites this paper
• Autocrine stimulation of human hepatocytes triggers late DNA synthesis and stabilizes long-term differentiation in vitro.

  2008cites this paper
• A new experimental model of isolated perfused pig liver to support acute hepatic failure.

  2007cites this paper
• A New Surgical Model for Hepatectomy in Pigs

  2007cites this paper
• Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.

  2007cites this paper